OI
42
-3
SYF
86
-6
ED
45
3
FOXA
52
-14
FRT
41
-2
ABT
59
2
COP
57
-2
SHW
62
-6
LRCX
37
-9
IFF
47
-4
KHC
9
-4
AAP
35
-9
DGX
48
11
SLG
57
-3
APH
65
-3
EMR
71
-3
EOG
56
-2
PAYX
48
-6
DD
53
-6
FTI
71
-7
OI
42
-3
SYF
86
-6
ED
45
3
FOXA
52
-14
FRT
41
-2
ABT
59
2
COP
57
-2
SHW
62
-6
LRCX
37
-9
IFF
47
-4
KHC
9
-4
AAP
35
-9
DGX
48
11
SLG
57
-3
APH
65
-3
EMR
71
-3
EOG
56
-2
PAYX
48
-6
DD
53
-6
FTI
71
-7
Financhill
Back

First Trust TCW Securitized Plus ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
27

DEED
First Trust TCW Securitized Plus ETF

Last Price:
20.78
Seasonality Move:
1.1%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
27
First Trust TCW Securitized Plus ETF (DEED) is a Sell

Is First Trust TCW Securitized Plus ETF a Buy, Sell or Hold?

  • The current First Trust TCW Securitized Plus ETF [DEED] share price is $20.77. The Score for DEED is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • DEED is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DEED Stock Price Chart

What is First Trust TCW Securitized Plus ETF's stock price today?

  • The First Trust TCW Securitized Plus ETF share price today is $20.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DEED is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DEED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 35.51 Sell
Chaikin Money Flow: 2903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.79 - 21.19) Sell
Bollinger Bands (100): (20.84 - 21.64) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DEED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.82 Sell
20-day SMA: 20.9 Sell
50-day SMA: 21.35 Sell
200-day SMA: 20.9 Sell
8-day EMA: 20.82 Sell
20-day EMA: 20.94 Sell
50-day EMA: 21.14 Sell
200-day EMA: 21.03 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Trust TCW Securitized Plus ETF Earnings Growth & DEED Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Trust TCW Securitized Plus ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):